Clinical trial

Performance of PEAR 2.0 Software in Prescribing Biotherapy in Patients With Rheumatoid Arthritis

NCT06186375

Study summary

ClinicalTrials.gov

Performance of PEAR 2.0 Software in Prescribing Biotherapy in Patients With Rheumatoid Arthritis

Design: OBSERVATIONAL · Status: ACTIVE NOT RECRUITING · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Patients with planned biotherapy Find medicine records · Find other trials using this name

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2023-05-05

PhaseN/A

Conditions

Polyarthritis; Rheumatoidunresolved

Interventions

Patients with planned biotherapyOTHER

Sponsors & collaborators

CEN Biotechlead sponsor

MYEXPRESIONcollaborator

Mapped research locations

LilleFrance1 DijonFrance1 OrléansFrance1 Saint-Priest-en-JarezFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06186375 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.